Endoscopic Treatment Articles & Analysis
12 news found
In announcing the Top 10 Endoscopy Device Providers for 2021, the magazine wrote: “The increasing demand for minimally invasive surgeries, and rising adoption of endoscopes for treatment and diagnosis, along with the ever-evolving healthcare technology realm, is breathing a fresh air of innovation into the endoscopy devices market…. ...
The first product candidate, ESO-101, is loaded with mometasone furoate, an anti-inflammatory corticosteroid and well-known active substance approved as a topical treatment for asthma and skin conditions, and is thus well suited as a locoregional treatment for EoE. ...
Anuncia Anuncia is a spin-off of Alcyone that wants to develop devices for better treatment of hydrocephalus (the buildup of fluid in the cavities deep within the brain). ...
Scivita Medical is a high-tech enterprise engaged in the field of optical diagnosis and treatment, multidimensional images development, high-performance materials research and precision manufacturing with minimally invasive medical treatment. ...
We believe there remains a significant treatment gap between medical management and invasive surgery. It is within this gap that EndoBarrier has the potential to make the most significant impact on patients’ lives,” said Mr. ...
” About GI Dynamics GI Dynamics®, Inc. is the developer of EndoBarrier®, the first endoscopically delivered medical device for the treatment of type 2 diabetes and the reduction of obesity. ...
(ASX:GID) is the developer of EndoBarrier®, the first endoscopically delivered medical device for the treatment of type 2 diabetes and the reduction of obesity. ...
(ASX:GID) is the developer of EndoBarrier®, the first endoscopically delivered medical device for the treatment of type 2 diabetes and the reduction of obesity. ...
(ASX:GID) is the developer of EndoBarrier®, the first endoscopically delivered medical device for the treatment of type 2 diabetes and the reduction of obesity. ...
(ASX:GID) is the developer of EndoBarrier®, the first endoscopically delivered medical device for the treatment of type 2 diabetes and the reduction of obesity. ...
(ASX:GID) is the developer of EndoBarrier®, the first endoscopically delivered medical device for the treatment of type 2 diabetes and the reduction of obesity. ...
The DiLumen Ik knife is part of a growing platform of accessories that work in conjunction with the second-generation DiLumen C2™ EIP, which is designed to provide complete positioning of an endoscope in the large intestine and assist with optical visualization, diagnosis and endoscopic treatment. Other DiLumen accessories are: ...